November 2026
1. CHEN Y, Liu J, Wang W, Xiang L, et al
   [Corrigendum] High expression of hnRNPA1 promotes cell invasion by inducing EMT in gastric cancer.
   Oncol Rep. 2026;56:192.
   

   >> Share

   
   October 2026
2. XIA S, Zhang X, Tang L, Li A, et al
   Molecular classification and precision therapy in gastric cancer: Current advances and future perspectives (Review).
   Oncol Rep. 2026;56:174.
   

   >> Share

   
   September 2026
3. CAI X, He Y, Kang L, Zhou D, et al
   Identification of RRM2 as a key regulator of malignant epithelial cells in gastric cancer through single?cell transcriptomics.
   Oncol Rep. 2026;56:154.
   

   >> Share

   
   August 2026
4. ZENG A, Wang T, Song J, Zhu L, et al
   PIN1 inhibits ferroptosis in gastric cancer cells by regulating the CPEB1?GPX4 pathway.
   Oncol Rep. 2026;56:151.
   

   >> Share

   
   July 2026
5. XU Y, Wang W, Zhang Y, Fan Y, et al
   Dual roles of lactylation modification in gastric cancer: Crosstalk between metabolic reprogramming and epigenetic regulation (Review).
   Oncol Rep. 2026;56:133.
   

   >> Share

   
   May 2026
6. WANG TA, Zhang XD, Guo XY, Xian SL, et al
   [Corrigendum] 3?Bromopyruvate and sodium citrate target glycolysis, suppress survivin, and induce mitochondrial?mediated apoptosis in gastric cancer cells and inhibit gastric orthotopic transplantation tumor growth.
   Oncol Rep. 2026;55:91.
   

   >> Share

   
   
7. SHI ZY, Ding ZR, Huang YL, Lei YR, et al
   Silencing of SIVA?1 promotes cisplatin resistance in gastric cancer via the Bcl?2/BAX?mediated mitochondria?dependent apoptosis pathway.
   Oncol Rep. 2026;55:95.
   

   >> Share

   
   April 2026
8. SUN T, Jia Y, Xiao D
   [Expression of Concern] Interference of STAT 5b expression enhances the chemo?sensitivity of gastric cancer cells to gefitinib by promoting mitochondrial pathway?mediated cell apoptosis.
   Oncol Rep. 2026;55:70.
   

   >> Share

   
   
9. ZHANG T, Wang Y, Zhang J, Ye X, et al
   NR4A1 mediates chemotherapy?induced senescence via the PI3K/AKT pathway in gastric cancer cells.
   Oncol Rep. 2026;55:75.
   

   >> Share

   
   March 2026
10. JIN JJ, Dai FX, Long ZW, Cai H, et al
    [Corrigendum] CXCR6 predicts poor prognosis in gastric cancer and promotes tumor metastasis through epithelial-mesenchymal transition.
    Oncol Rep. 2026;55:38.
    

    >> Share

    
    
11. CONG N, Du P, Zhang A, Shen F, et al
    

    [Retracted] Downregulated microRNA?200a promotes EMT and tumor growth through the Wnt/beta?catenin pathway by targeting the E?cadherin repressors ZEB1/ZEB2 in gastric adenocarcinoma
    
    

    .
    Oncol Rep. 2026;55:40.
    

    >> Share

    
    
12. MU G, Li K, Hu C, Cai J, et al
    GPR176 enhances the epithelial?mesenchymal transition in gastric cancer cells by activating the PI3K/AKT/mTOR signaling pathway.
    Oncol Rep. 2026;55:48.
    

    >> Share

    
    January 2026
13. DU H, Hao XF, Lin BW, Zhang Y, et al
    Comparative analysis of the efficacy and safety of antibody?drug conjugates, radionuclide?drug conjugates and their combination targeting claudin 18.2 in gastric cancer treatment.
    Oncol Rep. 2026;55:4.
    

    >> Share

    
    December 2025
14. YE YW, Hu S, Shi YQ, Zhang XF, et al
    [Expression of Concern] Combination of the FGFR4 inhibitor PD173074 and 5?fluorouracil reduces proliferation and promotes apoptosis in gastric cancer.
    Oncol Rep. 2025;54:171.
    

    >> Share

    
    November 2025
15. YUAN X, Zhang T, Zheng X, Zhang Y, et al
    [Corrigendum] Overexpression of SET oncoprotein is associated with tumor progression and poor prognosis in human gastric cancer.
    Oncol Rep. 2025;54:143.
    

    >> Share

    
    October 2025
16. ZHU X, Jia L, Kuai X, Tang Q, et al
    High expression of eIF4A1 promotes angiogenesis through the NF?kappaB/VEGFA pathway and predicts poor prognosis in gastric cancer.
    Oncol Rep. 2025;54:118.
    

    >> Share

    
    September 2025
17. LU S, Ma Y, Sun T, Ren R, et al
    [Retracted] Expression of alpha?fetoprotein in gastric cancer AGS cells contributes to invasion and metastasis by influencing anoikis sensitivity.
    Oncol Rep. 2025;54:112.
    

    >> Share

    
    August 2025
18. GOMEZ-VALENZUELA F, Silva I, Retamal IN, Garcia-Bloj B, et al
    Comprehensive in?silico molecular analysis of early?onset gastric cancer identifies novel genes implicated in disease characterization and progression (Review).
    Oncol Rep. 2025;54:98.
    

    >> Share

    
    July 2025
19. QIU X, Pan T, Kuang T, Shen Y, et al
    DEPP1: A prognostic biomarker linked to stroma?rich and immunosuppressive microenvironment, promoting oxaliplatin resistance in gastric cancer.
    Oncol Rep. 2025;54:82.
    

    >> Share

    
    June 2025
20. CHEN P, Zhao D, Wang W, Zhang Y, et al
    [Corrigendum] High expression of RELM-alpha correlates with poor prognosis and promotes angiogenesis in gastric cancer.
    Oncol Rep. 2025;53:61.
    

    >> Share

    
    
21. LI Y, Wang K, Wei Y, Yao Q, et al
    [Retracted] lncRNA?MIAT regulates cell biological behaviors in gastric cancer through a mechanism involving the miR?29a?3p/HDAC4 axis.
    Oncol Rep. 2025;53:69.
    

    >> Share

    
    January 2025
22. YUN H, Dong F, Wei X, Yan X, et al
    Role and value of the tumor microenvironment in the progression and treatment resistance of gastric cancer (Review).
    Oncol Rep. 2025;53:14.
    

    >> Share

    
    October 2024
23. ZHU ZM, Li ZR, Huang Y, Yu HH, et al
    [Corrigendum] DJ?1 is involved in the peritoneal metastasis of gastric cancer through activation of the Akt signaling pathway.
    Oncol Rep. 2024;52:138.
    

    >> Share

    
    
24. XU G, Meng L, Yuan D, Li K, et al
    [Retracted] MEG3/miR?21 axis affects cell mobility by suppressing epithelial?mesenchymal transition in gastric cancer.
    Oncol Rep. 2024;52:140.
    

    >> Share

    
    August 2024
25. YAN H, Qiu C, Sun W, Gu M, et al
    [Retracted] Yap regulates gastric cancer survival and migration via SIRT1/Mfn2/mitophagy.
    Oncol Rep. 2024;52:108.
    

    >> Share

    
    February 2024
26. WANG Y, Zhang H, Ge S, Fan Q, et al
    [Retracted] Effects of miR?138?5p and miR?204?5p on the migration and proliferation of gastric cancer cells by targeting EGFR.
    Oncol Rep. 2024;51:18.
    

    >> Share

    
    November 2023
27. GONG YC, Ren GL, Liu B, Li F, et al
    [Retracted] miR?206 inhibits cancer initiating cells by targeting EHF in gastric cancer.
    Oncol Rep. 2023;50:197.
    

    >> Share

    
    October 2023
28. WANG JB, Jin Y, Wu P, Liu Y, et al
    [Corrigendum] Tumor suppressor PLZF regulated by lncRNA ANRIL suppresses proliferation and epithelial mesenchymal transformation of gastric cancer cells.
    Oncol Rep. 2023;50:187.
    

    >> Share

    
    July 2023
29. WANG L, Wu C, Xu J, Gong Z, et al
    GC‑MSC‑derived circ_0024107 promotes gastric cancer cell lymphatic metastasis via fatty acid oxidation metabolic reprogramming mediated by the miR‑5572/6855‑5p/CPT1A axis.
    Oncol Rep. 2023;50:138.
    

    >> Share

    
    May 2023
30. ZENG H, Wang J, Xu B, Deng H, et al
    Exosomal PD‑L1 promotes the formation of an immunosuppressive microenvironment in gastric diffuse large B‑cell lymphoma.
    Oncol Rep. 2023;49:88.
    

    >> Share

    
    
31. WANG H, Xiong M, Hu Y, Sun Y, et al
    [Retracted] MicroRNA‑19b inhibits proliferation of gastric cancer cells by targeting B‑cell CLL/lymphoma 3.
    Oncol Rep. 2023;49:104.
    

    >> Share

    
    April 2023
32. SUN DZ, Wei PK, Yue XQ
    Xiaotan Sanjie decoction normalizes tumor permissive microenvironment in gastric cancer (Review).
    Oncol Rep. 2023;49:74.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share